Diagnostics marketing that makes your evidence findable.
Your test is validated. Your analytical and clinical performance hold up. But the proof lives in the founder's head, a few conference decks, and a handful of relationships, and the lab directors, ordering clinicians, payers, and partners who decide adoption can rarely find it. D3 Digital Media installs the operating system that puts your validation and clinical utility in front of every buyer who evaluates you, without a single claim going out unsupported.
Book a Strategy Call See how WAVES worksIn diagnostics, rigorous work is invisible to the people who adopt it.
A founder-led diagnostics or in-vitro diagnostics company almost always has the hard part solved: a validated assay, defensible analytical and clinical accuracy, and a clear case for clinical utility. What it usually does not have is a repeatable way to put that evidence in front of the people who decide whether the test gets used. And in diagnostics, that is not one buyer. It is a lab director asking whether the assay will run cleanly on their bench, an ordering clinician asking whether the result changes what they do next, a payer asking whether the evidence supports coverage and reimbursement, and an investor or strategic partner asking whether the whole story holds together.
Each of those buyers evaluates on evidence, and each weighs it differently. Right now that evidence gets delivered by the founder, in person, one meeting at a time. It is the most expensive channel you own, it does not scale, and it goes quiet the moment the founder is deep in a validation study, a payer submission, or a financing round. Meanwhile the buyers who never met the founder are doing what everyone does now: searching for the test, reading what little is public, and asking an AI assistant to summarize the evidence. What they find is a thin site, a data sheet, and no answer to the one question that decides adoption.
Most diagnostics companies do not have a marketing problem. They have proof that is real and unfindable, which the market reads as proof that does not exist.
Two kinds of help, both wrong for diagnostics.
Agencies that do not read the evidence
They chase impressions and write claims that a lab director will not respect and that quietly overstate what your data supports. In diagnostics, an overstated claim is not just forgettable, it is a liability with regulators and a credibility loss with the exact scientific buyer you needed to win. You spend the engagement correcting them, then rewriting everything they hand back.
Consultants who only advise
They understand the evidence bar and the regulated buyer, and they hand you a positioning deck. Then the actual work, the site, the clinical-utility content, the search presence, the outreach cadence, lands back on a team already committed to validation, submissions, and the assay. Nothing gets built, and the deck ages in a drive.
Diagnostics needs a third option: a system that reads the evidence correctly, understands that labs, clinicians, payers, and partners each judge on different proof, leads with what the data supports rather than hype, keeps final approval on every claim with your team, and actually gets built and run. That is what WAVES is.
The WAVES operating system, tuned for the evidence-led buyer.
WAVES is five capabilities that compound into one loop. Each is adapted to how a diagnostic actually gets evaluated, across the distinct buyers who have to say yes, and you choose how much you run yourself with Coaching, or have our team run for you with WAVES Managed.
Web Presence
The site a lab, clinician, or partner reaches during evaluation, built to answer their real questions about validation, performance, and clinical utility, and structured so AI tools summarize your evidence accurately instead of guessing at it.
Authority
Search optimization and third-party visibility, from guest platforms to podcasts, that put your validation data and clinical utility case in front of buyers early, before the first sales conversation rather than after.
Voice
A captured voice profile for the founder and each scientific spokesperson, so everything sounds like your team and every claim stays inside what your evidence can support.
Engagement
A daily rhythm that surfaces the labs, clinicians, and partners signalling intent, so scarce outreach time lands on the accounts and relationships that actually move adoption.
Systems
A shared calendar, a CRM, a weekly scoreboard, and an approval workflow with your regulatory and compliance sign-off built into the step before anything publishes.
One conversation becomes a month of findable evidence.
The engine is built so the founder's scarcest resource, time and scientific judgment, produces the most output for the least effort. Here is the loop.
We capture the thinking
A recorded interview with the founder or a designated scientific lead about the assay, the validation, and why the result changes a decision. This is the only real time ask, usually a few hours a month, and it is the raw material for everything downstream.
We turn it into assets
Each conversation becomes a long-form article written for search and AI answers, short clips, posts, and, where it fits, a full episode. Evidence-led, framed for the lab, the clinician, the payer, and the partner, never overstated.
Your team approves
Nothing publishes without your regulatory and compliance sign-off. The approval step is built into the workflow, not bolted on after a claim slips through.
It compounds
Published work keeps ranking and keeps getting found by the next lab director or clinician who searches. The weekly scoreboard shows what is landing, and the quarterly checkup resets the plan.
An owned system, not a retainer you rent.
- A search-ready web presence that answers what labs, clinicians, payers, and partners actually evaluate before adoption.
- A captured voice profile for the founder and scientific spokespeople, so the evidence sounds like your team.
- A steady stream of evidence-led content, published to your site and structured so AI tools cite your validation and clinical utility correctly.
- An approval workflow with your regulatory and compliance sign-off in the loop before anything goes live.
- A CRM and a weekly scoreboard, so visibility and pipeline across your buyer types are measured, not assumed.
- A quarterly checkup that resets priorities against what actually moved adoption and interest.
Founder-led diagnostics and IVD, revenue or pre-launch.
The fit is a company where one leader still owns the decision and is willing to be in the strategic conversation, where the assay is validated and the evidence is real, and where visibility with labs, clinicians, payers, or partners is the constraint on the next stage. Diagnostics and IVD companies from roughly one million to fifty million dollars in revenue usually run this as Coaching. Pre-launch and pre-revenue companies usually run it as WAVES Managed, because they need visibility with partners and investors before they have the internal team to build it.
One honest note specific to this field: search demand for most diagnostic categories is small. Few buyers type your test into a search bar. That is why this system is built to work two ways. It makes you findable to the buyer who does search, and it gives your direct outreach something real to point to, a body of evidence and a voice that does the credibility work before and after the meeting. If you are still searching for your indication or your market, that is a different job, and we will say so on the call rather than sell you a system you are not ready to run.
The honest answers.
Who is diagnostics marketing with WAVES actually for?
Founder-led diagnostics and in-vitro diagnostics companies where the assay is validated and the constraint is visibility, not the science. Revenue-stage companies from about one million to fifty million dollars usually run it as Coaching. Pre-launch and pre-revenue companies that need partner and investor visibility usually run it as WAVES Managed. If you are still searching for your indication or market, we will tell you on the call.
Can you handle the regulatory and evidence bar without overstating our claims?
Yes, and it is the point. Your team keeps final approval on every claim and asset, and that sign-off is built into the workflow before anything publishes. We lead with what your validation and clinical data support, framed for the lab, clinician, payer, or partner reading it, and we document a voice so the message stays inside supportable claims. Compliance stays with you, by design.
We are pre-launch and pre-revenue. Is marketing worth it yet?
Often yes, on WAVES Managed. Pre-launch diagnostics frequently need visibility with strategic partners and investors before there is revenue or reimbursement, and that is exactly what Managed is built for: making your evidence and your team visible to the people who fund, partner with, and eventually adopt the test.
How is this different from hiring a diagnostics PR or med-comms firm?
PR and med-comms chase placements and produce assets on a project basis. WAVES installs an owned, compounding system you keep: your site, your search and AI presence, a documented voice, and a repeatable rhythm across your buyer types. Visibility does not stop when the retainer ends, and the evidence keeps getting found.
How much of the founder's time does this take?
On WAVES Managed, usually a few hours a month on camera for interviews, plus someone on your team to approve content each week. We handle production, publishing, and the systems. On Coaching, you build it with weekly guidance. The founder's scientific judgment is the input, not the founder's calendar.
What does it cost?
Coaching starts with a 997 dollar Onboarding Sprint billed with your first month, so month one is 1,694 dollars, then 697 dollars a month. WAVES Managed is scoped to your company, typically from 7,500 dollars a month, and starts with a 90-day pilot. We scope it on a strategy call.
See what findable evidence would do for your pipeline.
A working conversation, no pitch deck, no upsell. We will map where your proof is leaking, which buyers cannot find it, and what the operating layer would change, specific to your test.
Book a Strategy Call Life sciences marketing →